https://doi.org/10.4081/uij.2003.9

SOCIAL COST OF FEMALE URINARY INCONTINENCE: EPIDEMIOLOGY, COST OF ILLNESS AND COST/EFFECTIVENESS ANALYSIS

Vol. 17 No. 1 (2003)
Submitted: 21 June 2010
Accepted: 21 June 2010
Published: 1 July 2010
Abstract Views: 422
PDF: 301
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

F. BERNASCONI
nadia.moscato@pagepress.org
M. GRASSO
C. MANTOVANI
E. LUCCHINI
S. ARIENTI
C. CERRI
This paper presents the results of a broad, transversal, observational survey on the social cost of female urinary incontinence in the general female population, resident in the ASL3-Monza area. In this population, in an 18- 65 year old age group, the prevalence of U.I. observed is 28.5% (LIFE cases) and 18.6% (YEAR cases). The total number of incontinent women in the ASL3-Monza area and in the Lombardy Region can be estimated as follows: - ASL3-Monza 125,288 “LIFE” cases, 81,767 (18.6% of 439,609) “YEAR” cases. - Lombardy Region 1,119,480 “LIFE” cases, 730,608 (18.6% of 3,928,709) “YEAR” cases. In the light of the data collected, we can estimate that in the Lombardy Region and in the ASL3-Monza area, at least 379,600 (52% of 730,608) and 42,518 (52% of 81,767) incontinent women use protection and 175,200 (24% of 730,608) and 19,624 (24% of 81,767) consider using a pad to be the only useful solution to the problem. The “estimated” mean/annual cost per woman in an incontinent population with characteristics similar to those of the general female population of the ASL3-Monza is € 358,03, for a mean/life cost per woman of € 11.099,20.When there is no effective treatment of the symptom, we can estimate the following total cost/life in the ASL3-Monza area to be: 65,414 x 31 x € 358,03 = € 726.025.407. If the symptom disappears and the treatment is effective, this is also an advantage, apart from the obvious requirement for public health related to it, from a strictly pharmacological-economic point of view. The estimated total/life cost for the treatment (with the most effective medical, rehabilitative and/or surgical therapy available today) of a sample of 1,000 incontinent women of the ASL3- Monza area is significatively lower than the total cost/life expected in the case of persistence and “assistance” of the symptom: € 4.502.812,10 vs. € 23.451.270,02. Despite the methodological limits of a pilot study (single centre collection of data, limited samples, analysis of “theoretical” populations), from the data collected it appears clear that the more incisive and determined the strategy of information and education, and the fuller and earlier the diagnosis, the more significative the social- economic, as well as the psycho-social saving.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

BERNASCONI, F., GRASSO, M., MANTOVANI, C., LUCCHINI, E., ARIENTI, S., & CERRI, C. (2010). SOCIAL COST OF FEMALE URINARY INCONTINENCE: EPIDEMIOLOGY, COST OF ILLNESS AND COST/EFFECTIVENESS ANALYSIS. Urogynaecologia, 17(1), 9–42. https://doi.org/10.4081/uij.2003.9

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.